Proteomics evaluation of five economical commercial abundant protein depletion kits for enrichment of diseases‐specific biomarkers from blood serum

Abstract

AbstractBlood serum is arguably the most analyzed biofluid for disease prediction and diagnosis. Herein, we benchmarked five different serum abundant protein depletion (SAPD) kits with regard to the identification of disease‐specific biomarkers in human serum using bottom‐up proteomics. As expected, the IgG removal efficiency among the SAPD kits is highly variable, ranging from 70% to 93%. A pairwise comparison of database search results showed a 10%–19% variation in protein identification among the kits. Immunocapturing‐based SAPD kits against IgG and albumin outperformed the others in the removal of these two abundant proteins. Conversely, non‐antibody‐based methods (i.e., kits using ion exchange resins) and kits leveraging a multi‐antibody approach were proven to be less efficient in depleting IgG/albumin from samples but led to the highest number of identified peptides. Notably, our results indicate that different cancer biomarkers could be enriched up to 10% depending on the utilized SAPD kit compared with the undepleted sample. Additionally, functional analysis of the bottom‐up proteomic results revealed that different SAPD kits enrich distinct disease‐ and pathway‐specific protein sets. Overall, our study emphasizes that a careful selection of the appropriate commercial SAPD kit is crucial for the analysis of disease biomarkers in serum by shotgun proteomics.